Dark

SAN
Banco Santander S.A.
stock NYSE ADR

At Close

May 8, 2025 3:59:57 PM EDT

7.34USD+2.371%(+0.17)3,653,610

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 8, 2025 9:10:30 AM EDT

7.29USD+1.672%(+0.12)14,839

After-hours

May 8, 2025 4:47:30 PM EDT

7.33USD-0.136%(-0.01)295

OverviewOptionsHistoricalExchangesShortsNews

Jan 31, 2022

01:00AM EST CHMP recommendsapproval of Dupixent (dupilumab) forchildrenaged 6 to 11 years with severe asthma with type 2 inflammation GlobeNewswire Inc

Jan 28, 2022

08:05AM EST Santander Holdings USA, Inc. Announces Federal Reserve Approval Of Acquisition Of Shares It Does Not Own Of Santander Consumer USA Holdings Inc. And Expiration Of Its Tender Offer To Acquire Such Shares Benzinga

08:00AM EST Santander Holdings USA, Inc. Announces Federal Reserve Approval of its Acquisition of the Shares It Does Not Own of Santander Consumer USA Holdings Inc. and the Expiration of its Tender Offer to Acquire Such Shares Business Wire

Jan 24, 2022

11:34AM EST Citigroup Exits Mexico: What Investors Need To Know Benzinga

Jan 21, 2022

08:06AM EST Santander Announces Extension Of Tender Offer For Santander Consumer USA Until January 27 RTTNews

08:00AM EST Santander Holdings USA, Inc. Announces Extension of Tender Offer to Acquire Shares it Does not Own of Santander Consumer USA Holdings Inc. for $41.50 per Share Business Wire

Jan 19, 2022

01:00AM EST Second positive Phase 3Dupixent (dupilumab) trial confirms significant improvementsfor patients with prurigo nodularis GlobeNewswire Inc

Jan 13, 2022

08:06AM EST Santander Extends Tender Offer For Santander Consumer USA Until January 20 RTTNews

08:00AM EST Santander Holdings USA, Inc. Announces Extension of Tender Offer to Acquire Shares it Does not Own of Santander Consumer USA Holdings Inc. for $41.50 per Share Business Wire

Jan 7, 2022

01:00AM EST Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines GlobeNewswire Inc

Jan 6, 2022

10:26AM EST Santander Holdings USA, Inc. Announces Extension Of Tender Offer To Acquire Shares It Does Not Own Of Santander Consumer USA Holdings Inc. For $41.50 Per Share Benzinga

08:25AM EST Santander Announces Extension Of Tender Offer For Santander Consumer Until On January 12 RTTNews

08:00AM EST Santander Holdings USA, Inc. Announces Extension of Tender Offer to Acquire Shares it Does not Own of Santander Consumer USA Holdings Inc. for $41.50 per Share Business Wire

Jan 4, 2022

01:30AM EST Availability of the Q4 2021 Memorandum for modelling purposes GlobeNewswire Inc

Dec 27, 2021

10:07AM EST Price Over Earnings Overview: Banco Santander Benzinga

08:05AM EST Santander Holdings USA Announces Extension Of Tender Offer For Santander Consumer USA To Dec 29 RTTNews

08:04AM EST Santander Holdings USA Announces Extension Of Tender Offer To Acquire Shares It Does Not Own Of Santander Consumer USA Holdings Inc. For $41.50/Share Benzinga

08:00AM EST Santander Holdings USA, Inc. Announces Extension of Tender Offer to Acquire Shares it Does not Own of Santander Consumer USA Holdings Inc. for $41.50 per Share Business Wire

Dec 20, 2021

11:30PM EST Sanofi to acquireAmunix immuno-oncology pipeline with next generation Conditionally Activated Biologics GlobeNewswire Inc

Dec 17, 2021

08:06AM EST Santander Holdings USA Extends Tender Offer To Acquire Santander Consumer USA Holdings Shares To Dec 23 RTTNews

08:00AM EST Santander Holdings USA, Inc. Announces Extension of Tender Offer to Acquire Shares it Does Not Own of Santander Consumer USA Holdings Inc. for $41.50 per Share Business Wire

Dec 16, 2021

02:00AM EST Press Release: Gilles SCHNEPP takes over as Chairman of the GlobeNewswire Inc

Dec 15, 2021

01:30AM EST Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation GlobeNewswire Inc

Dec 14, 2021

09:00AM EST Data from two Phase 3 studiesdemonstrating fitusiran significantly reduced bleeds in people with hemophilia A or B, with or without inhibitors,were featured at ASHs plenary and late-breaking sessions GlobeNewswire Inc

Dec 13, 2021

01:00AM EST Positive Phase 3 Dupixent (dupilumab) data in children 6 months to 5 years with moderate-to-severe atopic dermatitis featured in RAD 2021 late-breaking session GlobeNewswire Inc

Dec 8, 2021

05:30PM EST New England Journal of Medicine publishes positive Phase 3 Dupixent (dupilumab) results in children with moderate-to-severe asthma GlobeNewswire Inc

10:04AM EST Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021 Benzinga

08:00AM EST Credit Suisse Downgrades Banco Santander to Neutral Benzinga

Dec 3, 2021

08:04AM EST Santander Holdings USA Says Extends Tender Offer To Acquire Shares It Does Not Own Of Santander Consumer USA Holdings RTTNews

08:00AM EST Santander Holdings USA, Inc. Announces Extension of Tender Offer to Acquire Shares it Does not Own of Santander Consumer USA Holdings Inc. for $41.50 per Share Business Wire

Dec 1, 2021

01:30AM EST Vaccines Investor Event: Sanofi reiterates confidence in strong GlobeNewswire Inc

01:00AM EST Sanofi to acquire Origimm Biotechnology in first move to treat GlobeNewswire Inc

Nov 26, 2021

08:07AM EST Santander Holdings USA Extends Tender Offer To Acquire Shares It Does Not Own Of Santander Consumer USA To Dec 2 RTTNews

08:00AM EST Santander Holdings USA, Inc. Announces Extension of Tender Offer to Acquire Shares it Does not Own of Santander Consumer USA Holdings Inc. for $41.50 per Share Business Wire

Nov 18, 2021

08:08AM EST Santander Holdings USA Announces Extension Of Tender Offer To Acquire Shares It Does Not Own Of Santander Consumer USA RTTNews

08:00AM EST Santander Holdings USA, Inc. Announces Extension of Tender Offer to Acquire Shares It Does Not Own of Santander Consumer USA Holdings Inc. for $41.50 per Share Business Wire

01:30AM EST Sanofi invests $180 million equity in Owkins artificial intelligence and federated learning to advance oncology pipeline GlobeNewswire Inc

Nov 10, 2021

08:21AM EST Santander Holdings USA, Inc. Announces Extension Of Tender Offer To Acquire Shares It Does Not Own Of Santander Consumer USAHoldings Inc. For $41.50/Share Benzinga

08:09AM EST Santander Holdings USA Extends Tender Offer To Buy Shares It Does Not Own Of Santander Consumer USA To Nov 17 RTTNews

08:00AM EST Santander Holdings USA, Inc. Announces Extension of Tender Offer to Acquire Shares it Does not Own of Santander Consumer USA Holdings Inc. for $41.50 per Share Business Wire

Nov 9, 2021

09:05AM EST Sanofi completes acquisition of Kadmon GlobeNewswire Inc

Nov 3, 2021

09:19AM EDT Santander Holdings USA, Inc. Announces Extension Of Tender Offer To Acquire Shares It Does Not Own Of Santander Consumer USA Holdings Inc. For $41.50/Share Benzinga

08:00AM EDT Santander Holdings USA, Inc. Announces Extension of Tender Offer to Acquire Shares It Does Not Own of Santander Consumer USA Holdings Inc. for $41.50 Per Share Business Wire

Oct 28, 2021

01:30AM EDT Sanofi : Strong Q3 performance drives guidance upgrade to around GlobeNewswire Inc

Oct 27, 2021

03:43AM EDT Earnings Scheduled For October 27, 2021 Benzinga

Oct 25, 2021

01:00AM EDT SecondDupixent (dupilumab) Phase 3 eosinophilic esophagitis trialto demonstrate significant disease improvements,underscoring role of type 2 inflammation in this complex disease GlobeNewswire Inc

Oct 22, 2021

01:00AM EDT Dupixent (dupilumab) is the first biologic to significantly reduce itch and skin lesions in Phase 3 trial for prurigo nodularis, demonstrating the role of type 2 inflammation in this disease GlobeNewswire Inc

Oct 20, 2021

05:30PM EDT FDA expands approval of Dupixent (dupilumab) to includechildren aged 6 to 11 years with moderate-to-severeasthma GlobeNewswire Inc

08:11AM EDT Santander Holdings USA Extends Tender Offer To Acquire Shares Of Santander Consumer USA Holdings To Nov 2 RTTNews

08:03AM EDT Santander Holdings USA Reports Extension Of Expiration Date For Previously-Announced Tender Offer To Buy Santander Consumer USA Holdings At $41.50/Share In Cash Benzinga

08:00AM EDT Santander Holdings USA, Inc. Announces Extension of Tender Offer to Acquire Shares It Does Not Own of Santander Consumer USA Holdings Inc. for $41.50 Per Share Business Wire

Oct 13, 2021

03:00AM EDT New long-term data reinforcing promising safety and efficacy profile of brain-penetrant tolebrutinib presented at ECTRIMS 2021 GlobeNewswire Inc

Sep 30, 2021

08:30AM EDT New, late-breaking data at EADV highlightsemerging clinical profile of amlitelimab(formerly KY1005)in adults with inadequately controlled moderate-to-severe atopic dermatitis GlobeNewswire Inc

Sep 28, 2021

02:00AM EDT Sanofi announces positive Phase 1/2 study interim results for its first mRNA-based vaccine candidate GlobeNewswire Inc

Sep 24, 2021

01:30AM EDT Sanofi: Availability of the Q3 2021 Memorandum for modelling purposes GlobeNewswire Inc

Sep 21, 2021

01:00AM EDT New Dupixent (dupilumab) datain patients as young as 6 years old withmoderate-to-severe atopic dermatitis to be presented at WCPD and EADV GlobeNewswire Inc

Sep 20, 2021

10:04AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2021 Benzinga

06:09AM EDT Exane BNP Paribas Downgrades Banco Santander to Neutral Benzinga

Sep 19, 2021

11:30AM EDT ESMO late-breaking data show Libtayo (cemiplimab) and chemotherapy first-line treatment combination significantly improved overall survival in patients with advanced NSCLC GlobeNewswire Inc

Sep 14, 2021

09:26AM EDT Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics GlobeNewswire Inc

Sep 9, 2021

11:05AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021 Benzinga

05:42AM EDT Jefferies Upgrades Banco Santander to Hold Benzinga

01:00AM EDT Sanofi provides update on Phase 3 studyevaluatingrilzabrutinib for the treatment of pemphigus GlobeNewswire Inc

Sep 8, 2021

01:00AM EDT Sanofi to acquireKadmon to further strengthen growth of transplant business GlobeNewswire Inc

Aug 30, 2021

01:00AM EDT Dupixent (dupilumab) pivotal trial meets all primary and secondary endpoints becoming first biologicmedicine to significantly reduce signs and symptoms of moderate-to-severe atopic dermatitis in children as young as 6 months GlobeNewswire Inc

Aug 6, 2021

11:42AM EDT FDA approves Nexviazyme (avalglucosidase alfa-ngpt), an important new treatment optionfor late-onset Pompe disease GlobeNewswire Inc

Aug 5, 2021

06:00AM EDT Phase 3 trial of Libtayo (cemiplimab) combined with chemotherapy stopped early due to significant improvement in overall survival in patients with first-line advanced non-small cell lung cancer GlobeNewswire Inc

Aug 3, 2021

01:00AM EDT Sanofi to acquire Translate Bio; advances deployment of mRNA technology across vaccines and therapeutics development GlobeNewswire Inc

Jul 29, 2021

01:31AM EDT Sanofi appoints new leaders to Executive Committee and announces GlobeNewswire Inc

01:30AM EDT Sales growth accelerated - Full-year guidance raised GlobeNewswire Inc

01:00AM EDT Dupixent (dupilumab) significantly improved itch and hives in patients with chronic spontaneous urticaria, a step forward in demonstrating the role of type 2 inflammation in these patients GlobeNewswire Inc

Jul 15, 2021

12:49PM EDT Santander's Santander Holdings USA To Purchase Amherst Pierpont For $600M Benzinga

12:48PM EDT CORRECTION: Santander's Santander Holdings USA To Purchase Amherst Pierpont For $600M Benzinga

12:45PM EDT Santander Consumer USA To Acquire Amherst Pierpont For ~$600M Benzinga

Jul 13, 2021

01:32AM EDT Sanofi announces Paris 2024 Premium partnership for the Olympic GlobeNewswire Inc

Jul 8, 2021

12:28PM EDT Banco Santander To Block Payments By UK Banking Customers To Binance Benzinga

Jun 29, 2021

04:01AM EDT Sanofi launches dedicated vaccines mRNA Center of Excellence GlobeNewswire Inc

Jun 28, 2021

02:00AM EDT Nirsevimab shows positive topline results in RSV Phase 2/3 MEDLEY GlobeNewswire Inc

01:00AM EDT Dupixent (dupilumab) SmPC updated with long-term data reinforcing well-established safety profile in adults with moderate-to-severe atopic dermatitis GlobeNewswire Inc

Jun 25, 2021

01:30AM EDT Sanofi: Availability of the Q2 2021 Memorandum for modelling purposes GlobeNewswire Inc

01:16AM EDT Sanofi: Libtayo (cemiplimab) approved by the European GlobeNewswire Inc

Jun 18, 2021

09:45AM EDT European Commission approves Aubagio (teriflunomide) GlobeNewswire Inc

Jun 11, 2021

03:00AM EDT New pivotal data at EHA 2021 reinforces sutimlimab as a first-in-class investigational C1s inhibitor with the potential to be the first approved treatment for hemolysis in peoplewith cold agglutinin disease, a serious and chronic autoimmune hemolytic anemia GlobeNewswire Inc

Jun 7, 2021

12:00PM EDT Sanofi launches its new global employee share ownership plan GlobeNewswire Inc

Jun 4, 2021

01:02AM EDT Sanofi Announces Partnership To Initiate Pivotal Trial Of An Oral SERD In The Adjuvant Setting RTTNews

01:00AM EDT amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer PR Newswire

01:00AM EDT Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptorpositive breast cancer GlobeNewswire Inc

Jun 3, 2021

08:00AM EDT Sanofi launches3million Planet Mobilization fund to supportemployees environmental projects GlobeNewswire Inc

Jun 1, 2021

06:45AM EDT Sanofi and Merck's first and only six-in-one pediatric combination vaccine now PR Newswire

01:00AM EDT Sanofi provides update on venglustat clinical program GlobeNewswire Inc

May 27, 2021

01:30AM EDT Sanofi and GSK initiateglobal Phase 3clinical efficacy study of COVID-19 vaccinecandidate GlobeNewswire Inc

May 19, 2021

05:45PM EDT Sanofi to showcase data fromits transformative oncology pipeline at 2021 ASCO Meeting GlobeNewswire Inc

05:00PM EDT Early amcenestrant data featured at ASCO support its potential to become a new endocrine backbone therapy for ER+/HER2- breast cancer GlobeNewswire Inc

May 17, 2021

10:00AM EDT Pivotal data at ATS 2021 show Dupixent (dupilumab) significantly reduced asthma attacks andimproved lung function in children GlobeNewswire Inc

01:30AM EDT Sanofi and GSK COVID-19 vaccine candidate demonstrates strong immune responses across all adultage groups in Phase 2 trial GlobeNewswire Inc

May 11, 2021

04:30PM EDT Cellectis and Sanofi partner on alemtuzumab as GlobeNewswire Inc

May 10, 2021

11:26AM EDT Stocks That Hit 52-Week Highs On Monday Benzinga

May 6, 2021

01:00AM EDT Sanofi establishes three-year collaboration with Stanford Medicine to PR Newswire

01:00AM EDT Sanofi establishesthree-year collaboration with Stanford Medicine to accelerate immunology research GlobeNewswire Inc

Apr 30, 2021

11:57AM EDT Annual General Meeting of April 30, 2021 GlobeNewswire Inc

Apr 28, 2021

10:03AM EDT Ethereum Hits New All-Time High Above $2,700 Benzinga

01:30AM EDT Sanofi continued its growth trajectory. Strong increase in Q1 2021 GlobeNewswire Inc

Apr 27, 2021

10:02PM EDT Ethereum Hits New All-Time High Above $2,700 Benzinga

Apr 26, 2021

02:00AM EDT Nirsevimab demonstrated protectionagainst respiratory syncytial virus diseasein healthy infants in Phase 3 trial GlobeNewswire Inc

Apr 23, 2021

10:05AM EDT New Dupixent (dupilumab) analyses reinforce long-term safety and efficacy profile in patients withatopic dermatitis as young as 6 years GlobeNewswire Inc

Apr 19, 2021

01:05PM EDT 12 European Soccer Clubs, Backed By JPMorgan Chase, Break From UEFA To Form Rival League Benzinga

01:00AM EDT European Commission approves second indication ofSarclisa (isatuximab) for relapsed multiple myeloma GlobeNewswire Inc

Apr 12, 2021

01:00AM EDT Sanofi to invest in a leading-edge production site in Singapore; continues to strengthen its vaccines manufacturing capacities GlobeNewswire Inc

Apr 9, 2021

01:45PM EDT Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas GlobeNewswire Inc

12:01AM EDT Interim late-breaking clinical data validate not-alpha profile of THOR-707 (SAR444245), Sanofis novel investigational IL-2 GlobeNewswire Inc

Apr 7, 2021

07:09AM EDT Sanofi Outlines Several Key Projects To Increase The Impact Of Corporate Social Responsibility Strategy RTTNews

07:01AM EDT Sanofi expands its social commitments, creates nonprofit unit to provide PR Newswire

03:04AM EDT Sanofi expands its social commitments, creates nonprofit unit to provide poorest countries with access to essential medicines GlobeNewswire Inc

Apr 6, 2021

12:12PM EDT Banco Santander shares were trading higher after Credit Suisse upgraded the stock from Neutral to Outperform. Benzinga

10:55AM EDT Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2021 Benzinga

06:16AM EDT Credit Suisse Upgrades Banco Santander to Outperform Benzinga

Mar 31, 2021

06:14PM EDT FDA approves Sarclisa(r) (isatuximab-irfc) in combination with carfilzomib and PR Newswire

05:15PM EDT FDA approves Sarclisa (isatuximab) in combination with carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma GlobeNewswire Inc

10:05AM EDT Sanofi to build new facility in Canada to increase global availability of high-dose influenza vaccine GlobeNewswire Inc

Mar 19, 2021

02:30AM EDT Availability of the Q1 2021 Memorandum for modelling purposes GlobeNewswire Inc

Mar 16, 2021

08:17AM EDT Santander Private Banking To Acquire Indosuez Wealth Management Business To Miami For $4.3B Benzinga

Mar 15, 2021

02:00AM EDT Phase 3 trial of Libtayo (cemiplimab) monotherapy in advanced cervical cancer stopped early for positive result on overall survival GlobeNewswire Inc

Mar 12, 2021

01:00AM EST Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate GlobeNewswire Inc

Mar 4, 2021

12:18PM EST Filing of the 2020 U.S. Form 20-F and French Document dEnregistrement Universel containing the Annual Financial Report GlobeNewswire Inc

01:00AM EST FDA accepts Dupixent (dupilumab) for review in children with moderate-to-severe asthma GlobeNewswire Inc

Mar 3, 2021

12:00PM EST Sanofis Board of Directors proposes the appointment of Christian Brandts and Barbara Lavernos as Board Members GlobeNewswire Inc

Feb 22, 2021

01:00PM EST FDA approves Libtayo (cemiplimab-rwlc) monotherapy for patients with first-line advanced non-small cell lung cancer with PD-L1 expression of 50% GlobeNewswire Inc

05:40AM EST Sanofi and GSK initiate new Phase 2 study of their adjuvanted recombinant protein-based COVID-19 vaccine candidate GlobeNewswire Inc

Feb 12, 2021

01:00AM EST The Lancet publishes Libtayo (cemiplimab) data showing extended overall survival in patients with first-line advanced non-small cell lung cancer with PD-L1 expression of 50% GlobeNewswire Inc

Feb 9, 2021

05:15PM EST FDA approves Libtayo (Cemiplimab-rwlc) as first immunotherapy indicated for patients with advanced basal cell carcinoma GlobeNewswire Inc

Feb 5, 2021

01:30AM EST Q4 2020 sales growth(2) of 4.2% and business EPS growth of 9.8% at CER GlobeNewswire Inc

01:30AM EST Capital Markets Day 2021: Sanofi progresses on its strategy to drive growth across its businesses and innovation with emerging leadership in immunology GlobeNewswire Inc

Feb 4, 2021

01:22PM EST Santander Holdings USA, Inc. and Santander Consumer USA Inc. Confirm PR Newswire

Feb 3, 2021

04:00AM EST Earnings Scheduled For February 3, 2021 Benzinga

Jan 20, 2021

12:15PM EST HSBC Upgrades Banco Santander to Buy Benzinga

Jan 12, 2021

08:30AM EST SANOFI unveils EUROAPI as the name of the new industry leading European API* company and appoints Karl Rotthier as its future Chief Executive Officer GlobeNewswire Inc

08:07AM EST Biond Biologics And Sanofi Enter Into Global Licensing Agreement For BND-22 RTTNews

Jan 11, 2021

02:30AM EST Sanofi to acquire Kymab, adding KY1005 to its pipeline, a human monoclonal antibody targeting key immune system regulator OX40L GlobeNewswire Inc

Dec 17, 2020

04:30PM EST Availability of the Q4 2020 Memorandum for modelling purposes GlobeNewswire Inc

Dec 15, 2020

01:00AM EST Sanofi renews partnership with the WHO to fight Neglected Tropical Diseases and eliminate sleeping sickness before 2030 GlobeNewswire Inc

Dec 11, 2020

08:30AM EST CHMP recommends approval of Plavix (clopidogrel) with aspirin in adults for certain types of strokes GlobeNewswire Inc

01:00AM EST Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in the elderly GlobeNewswire Inc

Dec 9, 2020

01:00AM EST Sanofi pioneers sustainable finance in the pharmaceutical industry with the signing of its two first sustainability-linked revolving credit facilities GlobeNewswire Inc

Nov 30, 2020

01:00AM EST Dupixent (dupilumab) approved by European Commission as first and only biologic medicine for children aged 6 to 11 years with severe atopic dermatitis GlobeNewswire Inc

Nov 23, 2020

04:00AM EST European Commission approves MenQuadfi, the latest innovation in meningococcal (MenACWY) vaccination for individuals 12 months of age and older GlobeNewswire Inc

Nov 18, 2020

01:12PM EST European Commission approves Supemtek (quadrivalent recombinant influenza vaccine) for the prevention of influenza in adults aged 18 years and older GlobeNewswire Inc

01:15AM EST Rilzabrutinib granted FDA Fast Track Designation for treatment of GlobeNewswire Inc

01:00AM EST FDA grants priority review for avalglucosidase alfa, a potential new therapy for Pompe disease GlobeNewswire Inc

Nov 13, 2020

07:00PM EST FDA issues Complete Response Letter for sutimlimab, an investigational treatment for hemolysis in adults with cold agglutinin disease GlobeNewswire Inc

09:13AM EST Banco Santander Plans To Cut Up To 4K Jobs In Spain Benzinga

Nov 2, 2020

01:15AM EST Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products GlobeNewswire Inc

Oct 29, 2020

02:30AM EDT Q3 2020 sales growth(2) driven by strong Dupixent and flu vaccines demand. GlobeNewswire Inc

02:00AM EDT Sanofi to evaluate the safety and efficacy of novel investigational candidate THOR-707 and KEYTRUDA(pembrolizumab) in pursuit of establishing a new treatment option in oncology GlobeNewswire Inc

Oct 28, 2020

02:00AM EDT Sanofi and GSK to support COVAX with 200 million doses of adjuvanted, recombinant protein-based COVID-19 vaccine GlobeNewswire Inc

Oct 26, 2020

08:00AM EDT Dupixent (dupilumab) late-breaking pivotal data showing significant improvement in eosinophilic esophagitis signs and symptoms presented for the first time at scientific meetings GlobeNewswire Inc

Oct 21, 2020

07:01AM EDT of free genetic testing and counseling for people with Parkinson's disease PR Newswire

Oct 16, 2020

08:00AM EDT CHMP recommends approval of Dupixent (dupilumab) for children aged 6 to 11 years with severe atopic dermatitis GlobeNewswire Inc

Oct 15, 2020

08:00AM EDT Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody levels in preclinical studies GlobeNewswire Inc

Oct 13, 2020

01:00AM EDT Dupixent (dupilumab) significantly reduced severe asthma attacks in children and is the only biologic to demonstrate improvement in childrens lung function in a randomized Phase 3 trial GlobeNewswire Inc

Oct 2, 2020

01:00AM EDT EMA accepts regulatory submission for avalglucosidase alfa, a potentially new standard of care enzyme replacement therapy for Pompe disease GlobeNewswire Inc

Sep 28, 2020

09:30AM EDT Sanofi completes Principia Biopharma Inc. acquisition GlobeNewswire Inc

Sep 25, 2020

01:30AM EDT Availability of the Q3 2020 Memorandum for modelling purposes GlobeNewswire Inc

Sep 24, 2020

10:01AM EDT Santander Bank Adopts Digital Mortgage And Home Equity Solution From Roostify PR Newswire

Sep 22, 2020

12:30PM EDT Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine GlobeNewswire Inc

01:00AM EDT Hart-Scott-Rodino waiting period expires for Sanofi?s acquisition of PrincipiaBiopharma Inc. GlobeNewswire Inc

Sep 21, 2020

08:25AM EDT Late-breaking ESMO presentation shows Libtayo (cemiplimab) monotherapy increases overall survival in first-line advanced non-small cell lung cancer with PD-L1 expression of 50% GlobeNewswire Inc

Sep 18, 2020

03:05AM EDT Positive pivotal data for Libtayo (cemiplimab) monotherapy in locally advanced basal cell carcinoma featured as a late-breaking presentation at ESMO GlobeNewswire Inc

01:00AM EDT Dr. Jean-Christophe Rufin appointed President of the Sanofi Espoir Corporate Foundation GlobeNewswire Inc

Sep 14, 2020

01:00AM EDT FDA grants Dupixent (dupilumab) Breakthrough Therapy GlobeNewswire Inc

Sep 10, 2020

01:00AM EDT New England Journal of Medicine publishes positive final results GlobeNewswire Inc

Sep 9, 2020

07:06AM EDT Sanofi Genzyme To Present New Data From Across Neurology Portfolio RTTNews

07:01AM EDT Sanofi Genzyme continues research to improve the lives of patients with PR Newswire

Sep 8, 2020

01:00AM EDT Dupixent (dupilumab) long-term data show sustained GlobeNewswire Inc

Sep 3, 2020

01:00AM EDT Sanofi and GSK initiate Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate GlobeNewswire Inc

Sep 1, 2020

01:00AM EDT Sanofi provides update on Kevzara (sarilumab) Phase 3 GlobeNewswire Inc

Aug 17, 2020

01:00AM EDT Sanofi to acquire Principia Biopharma PR Newswire

Jul 31, 2020

03:20PM EDT Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccine GlobeNewswire Inc

10:15AM EDT Santander Holdings USA, Inc. and Santander Consumer USA Holdings Inc. Provide PR Newswire

07:00AM EDT Sanofi and GSK selected for Operation Warp Speed to supply United States government with 100 million doses of COVID-19 vaccine GlobeNewswire Inc

Jul 30, 2020

02:15AM EDT Nirsevimab reduced respiratory syncytial virus infections requiring medical care in healthy premature infants in Phase 2b trial GlobeNewswire Inc

Jul 29, 2020

11:29AM EDT Online availability of Sanofis half-year GlobeNewswire Inc

08:02AM EDT Sanofi H1 2020 business EPS(1) growth of 9.2%(2) driven by transformation PR Newswire

01:00AM EDT Sanofi and GSK agree with the UK government to supply up to 60 GlobeNewswire Inc

Jul 14, 2020

07:02AM EDT Sanofi And MD Anderson Cancer Center Announce 5-Yr Strategic Collaboration To Accelerate Oncology Development RTTNews

07:01AM EDT Sanofi and MD Anderson announce strategic collaboration to accelerate oncology PR Newswire

document.getElementById("XX1GJm").onerror = function(){this.style.display='none';}; .dark-mode .SXfQPQ{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .SXfQPQ{ color: #333333; background-color: white; border: 2px solid #333333; }SANBanco Santander S.A.stock NYSE ADR

SAN
Banco Santander S.A.
stock NYSE ADR